The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Hutchison MediPharma
Phase II trial of surufatinib plus toripalimab for disease progression after first-line chemotherapy with platinum and fluoropyrimidine in advanced gastric or gastroesophageal junction adenocarcinoma.
 
Lin Shen
No Relationships to Disclose
 
Ming Lu
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Feng Ye
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Zhiping Li
No Relationships to Disclose
 
Xing Zhang
No Relationships to Disclose
 
Fei Yin
No Relationships to Disclose
 
Wei Chen
No Relationships to Disclose
 
Wang Sheng
No Relationships to Disclose
 
Yue Ma
No Relationships to Disclose
 
Yaqin Zhao
No Relationships to Disclose
 
Desheng Weng
No Relationships to Disclose
 
Xiaolei Yin
No Relationships to Disclose
 
Jinghong Zhou
Employment - Hutchison MediPharma
 
Haiyan Shi
No Relationships to Disclose
 
Panfeng Tan
Employment - Hutchison MediPharma
 
Weiguo Su
Employment - Hutchison MediPharma
Leadership - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma